From the abstract: The Biospecimen Reporting for Improved Study Quality (BRISQ) recommendations outlined herein are intended to apply to any study in which human biospecimens are used. The purpose of reporting these details is to supply others, from researchers to regulators, with more consistent and standardized information to better evaluate, interpret, compare, and reproduce the experimental results. The BRISQ guidelines are proposed as an important and timely resource tool to strengthen communication and publications around biospecimen-related research and help reassure patient contributors and the advocacy community that the contributions are valued and respected.This article was published simultaneously in Biopreservation and Biobanking by Mary Ann Liebert, Inc. Publishers; Journal of Proteome Research by American Chemical Society Publications; and Cancer Cytopathology by Wiley-Blackwell, on behalf of the American Cancer Society.PubMed Link